# Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention

> **NCT00947635** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 46 (actual)

## Conditions studied

- Immunosuppression
- Hyperlipidemias
- Diabetes Mellitus, Type 1

## Interventions

- **DIETARY_SUPPLEMENT:** Dietary intervention - supplements

## Key facts

- **NCT ID:** NCT00947635
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2009-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947635, "Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00947635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*